Selected publications:
• Lipiński PFJ, Szűcs E, Jarończyk M. Kosson P, Benyhe S, Misicka A, Dobrowolski JCz and Sadlej J. An excursion into secondary pharmacology of fentanyls with potential implications for drug design: σ1 receptor. Treatments, Mechanisms, and Adverse Reactions of Anesthetics and Analgesics, Academic Press, 2022, p: 89-100 DOI: 10.1016/B978-0-12-820237-1.00010-7,
• Dyniewicz, J.; Lipiński, P.F.J.; Kosson, P.; Bochyńska-Czyż, M.; Matalińska, J.; Misicka, A. Antinociceptive and cytotoxic activity of opioid peptides with hydrazone and hydrazide moieties at the C-terminus. Molecules, 2020, 25, 3429. DOI: 10.3390/molecules25153429
• Muchowska A, Redkiewicz P, Różycki K, Matalińska J, Lipiński PFJ, Czuwara J, Kosson P. The analgesic hybrid of dermorphin/substance P and analog of enkephalin improve wound healing in streptozotocin-induced diabetic rats. Wound Repair Regen. 2020 Mar;28(2):177-184. DOI: 10.1111/wrr.12775.
• Bochynska-Czyz M, Redkiewicz P, Kozlowska H, Matalinska J, Konop M, Kosson P. Can keratin scaffolds be used for creating three-dimensional cell cultures? Open Med. 2020 Apr 3;15:249-253. DOI: 10.1515/med-2020-0031
• Matalińska J, Lipiński PFJ, Kotlarz A, Kosson P, Muchowska A, Dyniewicz J. Evaluation of receptor affinity, analgesic activity and cytotoxicity of a hybrid peptide, AWL3020. Int J Pept Res Ther 2020. DOI:10.1007/s10989-020-10051-5
• Lipiński PFJ, Szűcs E, Jarończyk M, Kosson P, Benyhe S, Misicka A, Dobrowolski JC, Sadlej J. Affinity of fentanyl and its derivatives for the σ1-receptor. Medchemcomm. 2019 Jun 13;10(7):1187-1191. DOI: 10.1039/c9md00222g
• Lipiński PFJ, Kosson P, Matalińska J, Roszkowski P, Czarnocki Z, Jarończyk M, Misicka A, Dobrowolski JC, Sadlej J. Fentanyl family at the mu-opioid receptor: uniform assessment of binding and computational analysis. Molecules. 2019 Feb 19;24(4):740. DOI: 10.3390/molecules24040740
• Tymecka D, Puszko AK, Lipiński PFJ, Fedorczyk B, Wilenska B, Sura K, Perret GY, Misicka A. Branched pentapeptides as potent inhibitors of the vascular endothelial growth factor 165 binding to Neuropilin-1: Design, synthesis and biological activity. Eur J Med Chem. 2018 Oct 5;158:453-462. DOI: 10.1016/j.ejmech.2018.08.083
• Laskowska AK, Puszko AK, Sosnowski P, Różycki K, Kosson P, Matalińska J, Durlik M, Misicka A. Opioid tripeptides hybridized with trans-1-cinnamylpiperazine as proliferation inhibitors of pancreatic cancer cells in two- and three-dimensional in vitro models. ChemMedChem. 2017 Oct 9;12(19):1637-1644. DOI: 10.1002/cmdc.201700453
• Niescioruk A, Nieciecka D, Puszko AK, Królikowska A, Kosson P, Perret GY, Krysinski P, Misicka A. Physicochemical properties and in vitro cytotoxicity of iron oxide-based nanoparticles modified with antiangiogenic and antitumor peptide A7R. J Nanopart Res. 2017;19(5):160. DOI: 10.1007/s11051-017-3859-x
• Grabowska K, Puszko AK, Lipiński PF, Laskowska AK, Wileńska B, Witkowska E, Perret GY, Misicka A. Structure-activity relationship study of a small cyclic peptide H-c[Lys-Pro-Glu]-Arg-OH: a potent inhibitor of Vascular Endothelial Growth Factor interaction with Neuropilin-1. Bioorg Med Chem. 2017 Jan 15;25(2):597-602. DOI: 10.1016/j.bmc.2016.11.024
